大流行
病毒学
冠状病毒
2019年冠状病毒病(COVID-19)
爆发
严重急性呼吸综合征冠状病毒2型(SARS-CoV-2)
免疫
疾病
医学
纳米技术
传染病(医学专业)
免疫学
免疫系统
材料科学
病理
作者
Marcelly Chue-Gonçalves,Giovana Nicolete Pereira,Lígia Carla Faccin‐Galhardi,Renata Katsuko Takayama Kobayashi,Gerson Nakazato
出处
期刊:Nanomaterials
[Multidisciplinary Digital Publishing Institute]
日期:2021-11-19
卷期号:11 (11): 3118-3118
被引量:14
摘要
In view of the current Coronavirus Disease 2019 (COVID-19) pandemic outbreak, the research community is focusing on development of diagnostics, treatment, and vaccines to halt or reverse this scenario. Although there are already various vaccines available, adaptive mutations in the SARS-CoV-2 genome can alter its pathogenic potential and, at the same time, increase the difficulty of developing drugs or immunization by vaccines. Nanotechnology carries a potential to act in all stages in fighting this viral disease, with several possibilities of strategies such as applying nanoparticles directly as antivirals in delivery systems against these viruses or incorporating them in materials, with power of achievement in therapeutics, vaccines and prevention. In this paper, we review and bring insights of recent studies using metal nanocomposites as antivirals against coronavirus and structurally similar viruses.
科研通智能强力驱动
Strongly Powered by AbleSci AI